PGY2 Oncology Pharmacy Residency Program


Cowell Family Cancer Center, Traverse City, MI

Residency Program Overview

The PGY2 oncology pharmacy residency is a new program conducted primarily at the Cowell Family Cancer Center and Munson Medical Center. This residency program provides one year of specialized training. Upon completion, graduates will be prepared to confidently practice as a successful oncology pharmacist in direct-patient care, research, or operational settings, as well as equipped with the knowledge and skills to sit for and obtain board certification.

The oncology service line has ample opportunities for exposure to nearly all required patient care activities and those that are not available here will be coordinated with outside facilities.

Residents participate in both direct and indirect patient care activities as determined by the program with guidance from the American Society of Health-System Pharmacists (ASHP). They gain exposure and experience in required disease states to practice comprehensive medication management related to malignancies, associated symptoms, and supportive care. 

About the Cancer Program at Munson Medical Center

The cancer program at Munson Medical Center is well-established with eight medical oncologists, five radiation oncologists, one gynecologic oncologist, five nurse practitioners, and a physician’s assistant. Cancer services have expanded greatly in recent years, leading to the construction of a new, state-of-the-art facility, which opened in 2016.

The Cowell Family Cancer Center occupies a three-story building on the medical campus, allowing for multidisciplinary services at one site. These include radiation oncology, laboratory services, infusion, physician offices, research, and a health and wellness suite with integrative services. The infusion suite on the second floor has 43-chairs and a dedicated oncology pharmacy at its center, staffed by six certified pharmacy technicians and seven oncology pharmacists, four of whom are board certified. The oncology pharmacists work closely with the health care team to optimize patient care.


ASHP Accreditation status: Pre-candidate

The program will apply for candidate status when the initial resident starts and accreditation would retroactively include this date such that the resident will have an opportunity to graduate from an ASHP-accredited PGY2 program in the first program year.


Program Summary

Residency Positions Available
One resident is accepted each year.

Beginning Date
The first Monday on or after July 1. (Residents must be a licensed pharmacist in the State of Michigan no later than August 1.) 

Minimum Qualifications
Eligible applicants must have graduated from an ACPE-accredited college or school of pharmacy and successfully completed an ASHP-accredited PGY1 Pharmacy Residency.

Application Deadline
January 10th, 2020


Learning Experiences

4 Week Core

  • Orientation
  • Inpatient Oncology
  • Gynecologic Oncology
  • Inpatient Stem Cell Transplant
  • Outpatient Infusion Suite I
  • Outpatient Infusion Suite II
  • Investigational Drug Service

Possible Electives (more may be available based on resident interests)

  • Pain/Palliative Care
  • Pediatrics
  • Benign Hematology
  • Oncology Supportive Care
  • Multidisciplinary Clinic

Longitudinal Core

  • Oncology Drug Information
  • Research
  • Oncology Pharmacy Operations
  • Oncology Pharmacy Administration 

Resident Benefits

  • Insurance (health, dental, life, disability) 
  • Travel Stipend: Amount is determined each year for professional leave and may not cover all travel expenses.
  • Paid time off (PTO) – including 2 weeks’ vacation 
  • Stipend: ~$50,000

PGY2 Oncology Residency Program Director

Claire Boomershine, PharmD, BCOP
Email: cboomershine@mhc.net
Phone: (231) 935-6734